Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I.
Journal: Journal of psychopharmacology (Oxford, England)
Volume:
Issue:
Year of Publication:
Affiliated Institutions:
Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
UCL School of Pharmacy, London, UK.
National Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London, UK.
Department of Child and Adolescent Psychiatry, Nottinghamshire Healthcare NHS Foundation Trust, Queen's Medical Centre, Nottingham, UK.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.
Division of Psychiatry, Imperial College London, London, UK.
School of Clinical Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Academic Psychiatry, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Abstract summary
As Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most common pitfalls, and how to avoid them, in child and adolescent psychopharmacology. In this paper, we specifically addressed common pitfalls in the pharmacological treatment of attention-deficit/hyperactivity disorder, anxiety, bipolar disorder, depression, obsessive-compulsive disorder and related disorders, and tic disorder. Pitfalls in the treatment of other disorders are addressed in a separate paper (part II).
Authors & Co-authors:
Cortese
Besag
Clark
Hollis
Kilgariff
Moreno
Nicholls
Wilkinson
Woodbury-Smith
Sharma
Study Outcome
Source Link: Visit source